Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen

M R Kraus1, A Schäfer, T Bentink

  • 1Department of Gastroenterology and Hepatology, Medizinische Poliklinik, University of Würzburg, Klinikstrasse 6-8, D-97070 Würzburg, Germany. kraus_m@klinik.uni-wuerzburg.de

Insights

Antiviral therapy for hepatitis C can decrease male libido and cause erectile dysfunction. This study links these issues to reduced testosterone and increased depression during treatment.

Area of Science:

  • Hepatology
  • Endocrinology
  • Psychiatry

Background:

  • Hepatitis C antiviral therapy can cause sexual dysfunction in men.
  • Underlying factors contributing to sexual dysfunction during treatment are not well understood.

Purpose of the Study:

  • To investigate the impact of interferon-based antiviral therapy on male sexual function.
  • To assess the relationship between sex hormone levels, depression, and sexual dysfunction in patients with chronic hepatitis C.

Main Methods:

  • Prospective study of 34 male patients undergoing interferon alfa-2b and ribavirin therapy.
  • Monitored changes in free and total testosterone, dehydroepiandrosterone sulfate, prolactin, sex hormone-binding globulin, FSH, and LH.
  • Assessed depression using the Hospital Anxiety and Depression Scale and sexual dysfunction via Symptom Checklist 90 Item Revised and a sexual arousal disorder scale.

Main Results:

  • Significant decreases in free and total testosterone levels were observed during therapy, correlating with reduced libido and sexual function.
  • Increased depression scores were associated with sexual dysfunction.
  • No significant correlation was found between androgen levels and depression.

Conclusions:

  • Hepatitis C antiviral therapy is associated with decreased sexual function in men.
  • This decrease is linked to both reduced androgen levels and increased depressive symptoms.
  • Findings suggest a multifactorial cause for sexual dysfunction during treatment, impacting patient care.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...